Everglades Biopharma LLC

Pearland, TX

UEI
Y8MLVKZH8TT3
CAGE
7JZJ1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Business
  • Asian-Pacific American Owned
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
518 N Elder Grove Dr, Pearland, TX 77584, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A new drug entity for combination therapy of diabetic retinopathy R43EY032827 National Eye Institute (NIH) $769,746
Anti-angiogenic gene therapy of ocular vascular diseases R43EY031238 National Eye Institute (NIH) $224,746
Developing a novel therapy for diabetic retinopathy R44EY027665 National Eye Institute (NIH) $1,963,529
Developing a novel therapy for diabetic retinopathy R41EY027665 National Eye Institute (NIH) $224,985

SBA capabilities narrative

From the vendor's SBA profile

The mission of Everglades Biopharma, LLC is to develop biological drugs to treat human diseases.

Quick answers

Is Everglades Biopharma LLC registered in SAM.gov?

Yes. Everglades Biopharma LLC's SAM.gov registration is active through May 27, 2027.

What is Everglades Biopharma LLC's most recent federal award?

Everglades Biopharma LLC's most recent federal grant award is A new drug entity for combination therapy of diabetic retinopathy (R43EY032827), from National Eye Institute (NIH), on September 1, 2021.

On GovTribe

See Everglades Biopharma LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login